Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Crklem1/Cya
Common Name:
Crkl-KO
Product ID:
S-KO-01626
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Crkl-KO
Strain ID
KOCMP-12929-Crkl-B6J-VA
Gene Name
Crkl
Product ID
S-KO-01626
Gene Alias
1110025F07Rik; Crkol; snoop
Background
C57BL/6JCya
NCBI ID
12929
Modification
Conventional knockout
Chromosome
16
Phenotype
MGI:104686
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Crklem1/Cya mice (Catalog S-KO-01626) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000006293
NCBI RefSeq
NM_007764
Target Region
Exon 2
Size of Effective Region
~0.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
CRKL, also known as CT10 regulator of kinase-like, is a proto-oncogene encoding a SH2 and SH3 domain-containing adaptor protein. It is involved in multiple signaling pathways. For instance, it can regulate cell growth, differentiation, and migration by participating in pathways like PI3K/Akt, JNK/JUN, and the Hippo pathway [2,3,4]. CRKL's dysregulation has been associated with various diseases, especially cancers [2]. Genetic models, such as gene knockout (KO) and conditional knockout (CKO) mouse models, are valuable tools for studying its functions.

In hepatocellular carcinoma (HCC), CRKL overexpression nullifies anti-PD-1 treatment efficacy. CRKL promotes the infiltration of tumor-associated neutrophils (TANs), which block CD8+ T cell infiltration and function. Mechanistically, CRKL inhibits APC-mediated proteasomal degradation of β-catenin, promoting VEGFα and CXCL1 expression. Targeting CRKL using CRISPR-Cas9 gene editing restores the efficacy of anti-PD-1 therapy in orthotopic mouse models and patient-derived organotypic tumor spheroid models [1]. In other cancer types, gene knockdown and knockout of Crk and CrkL in tumor cell lines suppress tumor cell functions like proliferation, migration, and invasion [2]. In lung adenocarcinoma, depletion of CRKL blunts Hh-GLI2 pathway-mediated cell proliferation and invasion, and CRKL knockout cells are more sensitive to EGFR-TKI and chemotherapeutics [5]. In cervical cancer, knocking down CRKL led to reduced cell proliferation and regulated alternative splicing of cancer-related genes [6].

In conclusion, CRKL plays a crucial role in multiple biological processes, especially in cancer development and progression. Studies using KO/CKO mouse models and other loss-of-function experiments have significantly contributed to understanding its role in diseases like HCC, colorectal cancer, lung adenocarcinoma, and cervical cancer. These findings suggest that CRKL could be a potential therapeutic target for treating related diseases.

References:

1. Xie, Peiyi, Yu, Mincheng, Zhang, Bo, Guo, Lei, Li, Hui. 2024. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. In Journal of hepatology, 81, 93-107. doi:10.1016/j.jhep.2024.02.009. https://pubmed.ncbi.nlm.nih.gov/38403027/

2. Park, Taeju. 2021. Crk and CrkL as Therapeutic Targets for Cancer Treatment. In Cells, 10, . doi:10.3390/cells10040739. https://pubmed.ncbi.nlm.nih.gov/33801580/

3. Wesener, Marie C, Weiler, Sofia M E, Bissinger, Michaela, Schirmacher, Peter, Breuhahn, Kai. 2024. CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer. In International journal of molecular sciences, 25, . doi:10.3390/ijms25158549. https://pubmed.ncbi.nlm.nih.gov/39126118/

4. Guo, Chunmei, Gao, Chao, Lv, Xinxin, Liu, Shuqing, Sun, Ming-Zhong. 2021. CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt. In Journal of cellular and molecular medicine, 25, 2714-2724. doi:10.1111/jcmm.16303. https://pubmed.ncbi.nlm.nih.gov/33523562/

5. Liu, Xiaoming, Hu, Yan, Yu, Bentong, Peng, Kai, Gan, Xin. 2021. CRKL is a critical target of Hh-GLI2 pathway in lung adenocarcinoma. In Journal of cellular and molecular medicine, 25, 6280-6288. doi:10.1111/jcmm.16592. https://pubmed.ncbi.nlm.nih.gov/34076957/

6. Song, Qingling, Yi, Fengtao, Zhang, Yuhong, Yu, Han, Zhang, Yi. 2019. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell. In BMC cancer, 19, 499. doi:10.1186/s12885-019-5671-8. https://pubmed.ncbi.nlm.nih.gov/31133010/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest